• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Brain Behav Immun Health . Neuropsychological functioning in post-ICU patients after severe COVID-19 infection: The role of cognitive reserve

tetano

Editor, Senior Moderator
Brain Behav Immun Health


. 2022 May;21:100425.
doi: 10.1016/j.bbih.2022.100425. Epub 2022 Feb 7.
Neuropsychological functioning in post-ICU patients after severe COVID-19 infection: The role of cognitive reserve


Ana Costas-Carrera[SUP] 1 [/SUP], Marta Mónica Sánchez-Rodríguez[SUP] 1 [/SUP], Silvia Cañizares[SUP] 1 [/SUP], Antonio Ojeda[SUP] 2 [/SUP], Inés Martín-Villalba[SUP] 1 [/SUP], Mireia Primé-Tous[SUP] 1 [/SUP], Manuel Arturo Rodríguez-Rey[SUP] 1 [/SUP], Xavier Segú[SUP] 1 [/SUP], Francisco Valdesoiro-Pulido[SUP] 1 [/SUP], Roger Borras[SUP] 3 [/SUP], Josep Maria Peri[SUP] 1 [/SUP], Eduard Vieta[SUP] 1 3 4 5 [/SUP]



Affiliations

Abstract

Background: Cognitive manifestations associated with Severe Acute Respiratory Syndrome by Coronavirus 2 (SARS-CoV-2) are yet to be described in the existing literature. The aim of this exploratory study is to analyze the impact of severe SARS-CoV-2 infection on neuropsychological performance 6 months following hospital discharge, and to identify which medical variables predict worse outcome. In this context, we study if cognitive reserve (CR) may play a protective role on cognitive impairment.
Methods: We enrolled a cohort of 102 severe SARS-CoV-2 survivors who had been admitted to the Intensive Care Unit (ICU) and were contacted 6-months post discharge. A total of 58 agreed to participate in this 6-month follow-up study. Patients with previously known cognitive impairment were excluded. Demographic, clinical and laboratory data were collected. Firstly, to test the magnitude of neurocognitive sequalae two standard deviations below normative group were considered. Secondly, to analyze the main effects of medical variables on cognition and the interaction with cognitive reserve, ANCOVA analyses were performed.
Results: 53.4% obtained a score below the cutoff point (<26) in the screening test MOCA. ICU variables including mechanical ventilation, days of sedation or high CRP days were related with cognition. Cognitive Reserve (CR) interacted with delirium (F ​= ​6.8, p ​= ​0.01) and sedation days (F ​= ​9.40, p ​= ​0.003) to predict verbal memory and interacted with high CRP to predict phonemic fluency (F ​= ​6.47, p ​= ​0.01). Finally, no differences in neuropsychological performance were found depending on subjective cognitive impairment (SCI). However, patients with SCI had a higher score in the HAD anxiety subscale (t ​= ​-2.2; p ​< ​0.05).
Conclusions: In our cohort, cognitive dysfunction was related with ICU variables such as delirium, mechanical ventilation, and inflammation. CR modulated the impact of these variables on cognition. Cognitive complaints were related with anxiety but not with cognitive performance. Despite some limitations, including the need of replication of the findings with larger samples and control groups, our study suggests that high CR may be protective for severe COVID-19-related cognitive impairment.

Keywords: COVID-19; Cognitive impairment; Cognitive reserve; Coronavirus; ICU; Neurological manifestations; Neuropsychology; PICS; SARS-CoV-2.
 
Back
Top Bottom